NCT06189053View on ClinicalTrials.gov

A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)

Active, not recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Myocarditis
Trial Locations (1)

60654

Veradigm, Chicago

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY